Recro Pharma, Inc.·4

Jan 4, 8:54 PM ET

Myers Diane 4

4 · Recro Pharma, Inc. · Filed Jan 4, 2018

Insider Transaction Report

Form 4
Period: 2018-01-02
Myers Diane
Senior VP-Reg./Quality
Transactions
  • Award

    Common Stock

    2018-01-02+8,00016,803 total
  • Award

    Employee Stock Option (right to buy)

    2018-01-02+16,00016,000 total
    Exercise: $9.04Exp: 2028-01-02Common Stock (16,000 underlying)
Footnotes (2)
  • [F1]All shares of common stock are represented by unvested restricted stock units that will vest in four equal annual installments beginning January 2, 2019, subject to continued employment with the Company. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date.
  • [F2]The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT